RxDoctor Payments Data

Desarom Teso, MD

Surgery · Boston, MANPI 1558579565

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Medtronic at 50.5% of the total. Reporting peaked in 2019 at $2,281 and has fallen 54.6% since, to $1,036 in 2025.

$4,477in general payments, 2019–2025

Across 71 payments — averaging $63.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • W. L. Gore & Associates, Inc.$1K
  • Lemaitre Vascular, Inc.$406
  • Abbott$136
  • Johnson & Johnson$104
  • Boston Scientific$98
  • plus $444 from 12 others
$7,814in research payments, 2019–2025

Across 4 payments — averaging $1953.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$8K

What the payments were for

  • Speaking & faculty fees$1,78240%
  • Travel & lodging$66415%
  • Food & beverage$1,98644%
  • Education$461%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,477 in reported general payments places this provider in the 70th percentile of 694 surgery providers in Massachusetts.

See all surgery providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$26,604
Medicare patients
74
Services billed
143

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Boston

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →